CD30 sALCL restriction and item codes
Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
PBS CD30 sALCL restriction and item codes
Contact details
PBS Complex Drugs Programs team
Forms
CD30 positive systemic anaplastic large cell lymphoma - brentuximab vedotin - initial authority application (PB123)
Services Australia website
Lymphoma - systemic anaplastic large cell lymphoma
External website
PBS schedule for CD30 positive systemic anaplastic large cell lymphoma
FAQs from Service Officers
Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.
Item | Description |
1 | How is the quantity of brentuximab keyed in OPA? The quantity must be keyed as the dose required in milligrams. See Recording Dose and Dose Frequency in Online PBS Authorities System. |
2 | Does the prescriber require a new approval if a dose change is needed? Any: - dose change that is more than 10% (both increase or decrease) requires a new approval
- replacement for a change of dose should be keyed under the same item/restriction code as the previous approval, and
- rejection should be overridden with a comment 'dose change'
|
Expand all